What is the purpose of the exclusive conformance requirement for sequence presentation?

The exclusive conformance requirement for sequence presentation in patent applications serves a specific purpose. According to MPEP 2412.06:

“This requirement is necessary to minimize any confusion that could result if more than one format for representing sequence data was employed in a given application.”

By enforcing a standardized format for sequence representation, the USPTO aims to:

  • Ensure consistency across patent applications
  • Facilitate easier review and comparison of sequence data
  • Reduce potential misinterpretations or ambiguities in sequence information
  • Streamline the patent examination process for biotechnology-related inventions

This requirement applies to all applications filed on or after July 1, 2022, that disclose nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).

To learn more:

Topics: MPEP 2400 - Biotechnology, MPEP 2412.06 - The Requirement For Exclusive Conformance; Sequences Presented In Drawing Figures, Patent Law, Patent Procedure
Tags: biotechnology patents, Exclusive Conformance, Sequence Presentation